An extension study to phase IIb dose-finding study of entacapone in patients with Parkinson's disease with end-of-dose wearing-off.

Trial Profile

An extension study to phase IIb dose-finding study of entacapone in patients with Parkinson's disease with end-of-dose wearing-off.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Entacapone (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 28 Nov 2007 Status changed from in progress to completed.
    • 30 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top